Fisetin induces G0/G1 arrest and apoptosis via mTOR signalling in HSC-3 cells.
Listen to this summary
Fisetin, a natural flavonoid, is evaluated for its ability to kill and halt the growth of HSC-3 oral carcinoma cells, with a focus on whether it acts through the mTOR signalling pathway. The authors measured dose-dependent cytotoxicity (MTT assay, IC50), changes in mTOR-related gene expression (e.g., 4EBP1, Glut1, PKM2, RAPTOR, S6K1, SGK1) by qRT-PCR, and fisetin's binding to mTOR pathway proteins via molecular docking. They report that fisetin reduces proliferation-associated gene expression, promotes apoptotic gene expression, and binds strongly to mTOR signalling proteins, suggesting it as a candidate for oral cancer therapy pending in vivo and clinical studies.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of oral and maxillofacial pathology : JOMFP
View all →Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Patient education using 3D animation and graphic medicine-Explained through dental caries model.
Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Expression of endoglin (CD105) and its correlation with mast cells across different grades of oral epithelial dysplasia and oral squamous cell carcinoma: A retrospective comparative study.
Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Mitotic and apoptotic indices in oral epithelial dysplasia and oral squamous cell carcinoma: A systematic review.
Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Correlation of CD163-positive tumour-associated macrophages and β-catenin expression with histological grading in oral squamous cell carcinoma.
Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Clinical image-based artificial intelligence models for early detection and classification of oral cancer: A systematic review and meta-analysis.
Nov 18, 2026 · Journal of oral and maxillofacial pathology : JOMFP
Mitochondrial DNA mutations in oral squamous cell carcinoma: A systematic review and meta-analysis.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


